"Actavis" is a global international pharmaceutical company, which is the third largest in the world in the production
of generic medicines. It is focused on developing, manufacturing and distribution of generics, brands and bioequivalent
products. The company’s portfolio includes more than 750 products. Medicines are manufactured in 32 pharmaceutical
factories by standards (GMP), in accordance with the requirements of the European Union and the US Food and Drug
Administration (FDA), which is a guarantee of product safety.
"Actavis" conducts its own medicine development, including innovation in 18 research centers located in the USA, Europe
and Asia. Company promotes the development of medicine by organizing exhibitions, conferences and symposia. It also
collaborates with a number of charitable organizations. "Actavis" devotes a lot of efforts for environmental protection. The company
has planned significant investments in environmental protection. This is an important factor in creating and maintaining the image of a
leading international generic company, which ensures the prompt introduction to the market of the latest generation of drugs at an affordable price!
